期刊文献+

ABCB11基因V444A位点多态性在新生儿胆汁淤积症中的意义 被引量:1

Significance of V444A polymorphism of ABCBll gene in neonatal cholestasis
原文传递
导出
摘要 目的探讨ABCB11基因中常见的多态性位点1331T〉C(V444A)变异在新生儿胆汁淤积症中的意义。方法选择192例新生儿胆汁淤积症患儿作为病例组,196例健康儿童作为健康对照组,采用TaqmanMGB荧光探针的方法对1331T〉C(V444A)位点进行检测。应用Fisher’s精确概率检验比较不同等位基因或基因型在2组中的差异,应用秩和检验比较不同基因型患儿γ-谷氨酰转肽酶、总胆红素和总胆汁酸水平的差异。结果1331T〉C(V444A)组成的TT、Tc和CC3种基因型在2组人群中的分布差异无统计学意义(P=0.530)。T等位基因在病例组中占29.9%,在健康对照组中占26.3%,2组比较差异无统计学意义(OR=1.12,P=0.264)。不同基因型患儿的γ-谷氨酰转肽酶、总胆红素和总胆汁酸水平比较差异亦均无统计学意义(P均〉0.05)。结论仅单个1331T〉C(V444A)位点变异并不增加新生儿胆汁淤积症的易感性。 Objective To explore the association between one common variant in ABCB11-1331T 〉 C (V444A) and neonatal cholestasis. Methods One hundred and ninety-two children with neonatal cholestasis were en- rolled as case group,and 196 healthy children were selected as healthy control group. The SNP site of V444A was tested by fluorescent quantitative PCR. Fisher's exact test was performed to detect the differences in allele and genotype distribution between the 2 groups. Wilcoxon rank-sum test was used to test the differences of total bilirubin, total bile acid, γ- glutamyl transpeptidase levels among the patients with different genotypes. Results TT,TC and CC genotypic distribu- tion of V444A were not significantly different between patients and controls (P = 0. 530). The T allele in the case group accounted for 29.9%, in the healthy control group accounted for 26.3% ,there was no significant difference between the 2 groups( OR = 1. 12, P = 0. 264 ). Total bilirubin, total bile acid, γ-glutamyl transpeptidase levels in patients with different genotypes of V444A were also not statistically different ( all P 〉 0.05 ). Conclusion Only V444A variant may have no impacts on neonatal cholestasis.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2013年第2期92-94,共3页 Chinese Journal of Applied Clinical Pediatrics
基金 国家自然科学基金(81000149)
关键词 ABCB11基因 V444A 新生儿胆汁淤积症 ABCB11 gene V444A Neonatal cholestasis
  • 相关文献

参考文献13

  • 1Stokes CS,Lammert F. Transporters in cholelithiasis[J].Biological Chemistry,2012,(1-2):3-10.
  • 2Nicolaou M,Andress EJ,Zolnerciks JK. Canalicular ABC transporters and liver disease[J].Journal of Pathology,2012,(02):300-315.
  • 3Van der Woerd WL,van Mil SW,Stapelbroek JM. Familial cholestasis:progressive familial intrahepatic cholestasis,benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of prcgnancy[J].Best Practice and Research in Clinical Gastroenterology,2010,(05):541-553.
  • 4Beauséjour Y,Alvarez F,Beaulieu M. Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family[J].Canadian Journal of Gastroenterology,2011,(06):311-314.
  • 5Lam P,Soroka CJ,Boyer JL. The bile salt export pump:clinical and experimental aspects of genetic and acquired cholestatic liver disease[J].Seminars in Liver Disease,2010,(02):125-133.
  • 6Kubitz R,Brinkmeyer C,Sagir A. Genetic variants of the bile salt export pump:inducers and modifiers of liver diseases[J].Digestive Diseases,2011,(01):89-92.
  • 7Takeyama Y,Kanegae K,Inomata S. Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis[J].MEDICAL MOLECULAR MORPHOLOGY,2010,(03):134-138.
  • 8Pauli-Magnus C,Meier PJ,Stieger B. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy[J].Seminars in Liver Disease,2010,(02):147-159.
  • 9Stieger B,Geier A. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis,intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis[J].Expert Opin Drug Metab Toxicol,2011,(04):411-425.
  • 10Wadsworth CA,Dixon PH,Wong JH. Genetic factors in the pathogenesis of cholangiocareinoma[J].Digestive Diseases,2011,(01):93-97.

同被引文献31

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部